Identity
- Trade Name
- Uni FB tibial component LM/RL FDA UDI
- Generic Name
- Uncoated unicondylar knee tibia prosthesis, metallic FDA UDI
- Model / Reference
- 40100022 FDA UDI
Identifiers
- Primary DI / UDI-DI
- 04048844205379 FDA UDI
- FDA Product Code
- HSX FDA UDI
- GMDN Term
- Uncoated unicondylar knee tibia prosthesis, metallic FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 888.3520 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
FDA UDI
Single Use
Yes
FDA UDI
Implantable
Yes
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Uncoated unicondylar knee tibia prosthesis, metallic
Uni FB tibial component LM/RL by implantcast GmbH — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Uncoated unicondylar knee tibia prosthesis, metallic.
- ZUK — Smith & Nephew, Inc. · Class II
- AS univation® XF — AESCULAP, INC. · Class II
- ZUK — Smith & Nephew, Inc. · Class II
- ZUK — Smith & Nephew, Inc. · Class II
- Persona® Partial Knee System — Biomet Orthopedics, Inc. · Class II
- MOTO Partial Knee System - Medial — Medacta International · Class II
- MOTO Lateral Partial Knee System — Medacta International · Class II
- SIGMA — DEPUY (IRELAND) · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- implantcast GmbH
Sources (1)
- FDA UDI 9dd822db-1981-426d-8505-e834360b4412 33 fields · synced May 30, 2026